.INVESTIGATION EMPHASIZE.06 August 2024.
A large randomized regulated trial with cisgender ladies highlights the problems of fidelity to a day-to-day oral preexposure treatment program and shows that twice-yearly injection of lenacapavir may sustain helpful HIV protection degrees over 6 months.